DS
TNXP icon

David Shaw’s Tonix Pharmaceuticals TNXP Stock Holding History

David Shaw’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-8
Closed -$1.15M – 5778
2022
Q1 		$1.15M Sell
8
-21
-72% -$3.21M ﹤0.01% 3785
2021
Q4 		$6.68M Buy
29
+19
+190% +$6.04M 0.01% 2072
2021
Q3 		$4.02M Buy
10
+9
+900% +$4.38M ﹤0.01% 2333
2021
Q2 		$834K Buy
+1
New +$735K ﹤0.01% 3690
2016
Q4 		– Hold
0
– -$82K – 3598
2016
Q3 		– Hold
0
– – – 3298
2016
Q2 		– Hold
0
– – – 3046
2016
Q1 		– Hold
0
– – – 3004
2015
Q4 		– Hold
0
– – – 3012
2015
Q3 		– Hold
0
– – – 3370

Other funds holding TNXP

M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

David Shaw's TNXP Position: Q2 2022 in Review

David Shaw sold out of Tonix Pharmaceuticals (TNXP) in Q2 2022, closing a stake of 8 shares — an estimated $1.15M sold.

David Shaw first reported a position in TNXP in Q2 2021 and held it in 4 quarters. The position peaked at $6.68M in Q4 2021. 23 funds tracked by Wall St. Rank hold TNXP as of Q2 2022.

  • David Shaw reported no remaining Tonix Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • David Shaw sold 8 Tonix Pharmaceuticals shares in Q2 2022, an estimated $1.15M.
  • David Shaw first reported a position in Tonix Pharmaceuticals in Q2 2021 and held it in 4 quarters.
  • David Shaw's Tonix Pharmaceuticals position peaked at $6.68M in Q4 2021.
  • 23 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2022.

Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.